1. What data in particular will be shared?
   Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   Response - Clinical Study Report
   
   
3. Who will be able to view these files?
   Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
   


4. For what types of analyses will this data be available?
   Response - To achieve aims in the approved proposal.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [mishpall13@gmail.com].
   


6. For how long will this data be available start date provided 25-09-2025 and end date provided 25-09-2030?
   Response - Beginning 3 months and ending 5 years following article publication.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - NIL

Autism spectrum disorder is a neurodevelopmental and behavioural disorder that is characterised by a deficit in reciprocal social communication and stereotypical repetitive and restricted behaviour It is a complex impairment often appearing in early childhood The etiology is multifactorial and not fully understood Autism spectrum disorder ASD encompasses autistic disorder Aspergers syndrome and pervasive mental disorderThe clinical manifestations of ASD varies depending on the severity of the disorder  The prevalence of autism is rapidly increasing over the yearsThe global prevalence of autism is 1 in 100 as per the World Health Organization According to CDCs Autism and Developmental Disabilities Monitoring ADDM network about 1 in 36 children have been diagnosed with autism The prevalence of autism in India is 1 in 68 as per a study published in the Indian Journal of Pediatrics About 18 million children are affected by autism  Autism is 4 times more common in boys than girls Globally there has been a notable surge in occurrence of autism spectrum disorder Despite a lot of medical advancements there are no medications specifically to treat autism Secondgeneration antipsychotics risperidone and aripiprazole are two drugs that the US Food and Drugs Administration has approved for the treatment of autism It is efficacious in reducing some symptoms but it carries the risk of side effects like excessive weight gain hyperglycemia drowsiness sedation tremors and muscle stiffness The children may get relief from the previous symptoms with lots of new ones getting added Occupational therapy a psychosocial intervention is more popular in the management of autism that requires a significant investment of time and money placing a financial burden on families This increases a concern in health care professional and researchers ASD can be considered as a global pandemic which needs an early and effective intervention There is an equal and profound impact on the daytoday life of autistic individuals and their families The management of autism needs to be a multidisciplinary approach So in this context Ayurveda may play a significant role in the management of wellbeing cognition and overall behaviour Three treatment modalities are explained in the classical texts ofAyurveda viz daivavyapashraya yuktivyapashraya and sattvavajaya chikitsa This is a wholesome approach dealing with the physical mental as well as emotional wellbeing of the patient with minimal consumption of time and is costeffective This study is carried out to evaluate the effect of this treatment protocol in the management of ASD